Recombinant Proteins

p53
LBP
CEA
HLA
TCL
TTC
NPM
MAF
Bax
BID

TREM1 Human

Triggering Receptor Expressed on Myeloid Cells 1 Human Recombinant

TREM1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 209 amino acids (21-205 a.a.) and having a molecular mass of 23.3kDa.
TREM1 is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT18346
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

TREM2 Human

Triggering Receptor Expressed on Myeloid Cells 2 Human Recombinant

TREM2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 181 amino acids (19-161 a.a) and having a molecular mass of 20.4kDa.
TREM2 is fused to a 38 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT18422
Source
Escherichia Coli.
Appearance
Sterile Filtered colorless solution.

TREM2 Human, HEK

Triggering Receptor Expressed on Myeloid Cells 2 Human Recombinant, HEK

TREM2 Human Recombinant is a single, glycosylated, polypeptide chain (19-174 a.a) containing a total of 162 amino acids, having a molecular mass of 18.2 kDa.
TREM2 is  fused to a 6 amino acid His-tag at C-terminus and is purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT18482
Source

HEK293 Cells.

Appearance
Sterile Filtered colorless solution.
Definition and Classification

Triggering Receptor Expressed on Myeloid Cells (TREM) is a family of cell surface receptors that play a crucial role in the immune response. The most well-known members of this family are TREM-1 and TREM-2. TREM-1 is primarily involved in amplifying inflammatory responses, while TREM-2 has a more regulatory role, often inhibiting inflammation .

Biological Properties

Key Biological Properties: TREM-1 and TREM-2 are part of the immunoglobulin superfamily and are transmembrane proteins. They are involved in the regulation of inflammation and immune responses .

Expression Patterns and Tissue Distribution: TREM-1 is constitutively expressed on the surface of peripheral blood monocytes and neutrophils and is upregulated by toll-like receptor (TLR) ligands . TREM-2 is expressed on activated macrophages, immature dendritic cells, osteoclasts, and microglia .

Biological Functions

Primary Biological Functions: TREM-1 amplifies the immune response by promoting the production of proinflammatory cytokines and chemokines . TREM-2, on the other hand, plays a role in immune surveillance, cell-cell interactions, and tissue debris clearance .

Role in Immune Responses and Pathogen Recognition: TREM-1 enhances the toll-like receptor (TLR)-4-induced inflammatory response, which is crucial for pathogen recognition and the subsequent immune response . TREM-2 is involved in the phagocytosis of apoptotic cells and tissue debris, thus playing a role in maintaining tissue homeostasis .

Modes of Action

Mechanisms with Other Molecules and Cells: TREM-1 signals through the adapter protein DAP12, leading to the activation of downstream signaling pathways such as the MEK/ERK and NF-κB pathways . TREM-2 also signals through DAP12, activating the PI3K/Akt pathway, which promotes cell survival and phagocytosis .

Binding Partners and Downstream Signaling Cascades: TREM-1 and TREM-2 interact with various ligands, although the specific ligands for TREM-1 are not well-characterized . The activation of these receptors leads to the production of cytokines and chemokines, which amplify the immune response .

Regulatory Mechanisms

Regulatory Mechanisms Controlling Expression and Activity: The expression of TREM-1 is upregulated by TLR ligands, which are recognized during infections . TREM-2 expression is regulated by factors secreted in the extracellular environment, such as nucleotides and lipid mediators .

Transcriptional Regulation and Post-Translational Modifications: TREM-1 and TREM-2 are regulated at the transcriptional level by various cytokines and signaling pathways. Post-translational modifications, such as phosphorylation of DAP12, are crucial for the activation of downstream signaling pathways .

Applications

Biomedical Research: TREM-1 and TREM-2 are studied extensively for their roles in various diseases, including sepsis, autoimmune diseases, and cancers .

Diagnostic Tools: Elevated levels of soluble TREM-1 (sTREM-1) in the blood can serve as a biomarker for sepsis and other inflammatory conditions .

Therapeutic Strategies: Targeting TREM-1 and TREM-2 with specific inhibitors or activators holds potential for treating inflammatory diseases, autoimmune disorders, and cancers .

Role in the Life Cycle

Role Throughout the Life Cycle: TREM-1 and TREM-2 play essential roles from development to aging. TREM-1 is involved in the acute inflammatory response, while TREM-2 is crucial for tissue homeostasis and the resolution of inflammation .

From Development to Aging and Disease: During development, TREM-2 is involved in the maturation of dendritic cells and osteoclasts . In aging, dysregulation of TREM-2 is associated with neurodegenerative diseases such as Alzheimer’s disease .

© Copyright 2024 Thebiotek. All Rights Reserved.